Prostate Cancer Treatment Using Focused Ultrasound System Gets FDA Approval

Prostate Cancer Treatment Using Focused Ultrasound System Gets FDA Approval

The U.S. Food and Drug Administration (FDA) has approved SonaCare Medical's Sonablate 450 focused ultrasound system for ablation therapy on prostate tissue. A pioneer in high intensity focused ultrasound (HIFU) technologies, the Indianapolis, …

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.